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Since surgical resection is the principal treatment of gastric cancer, early detection is the only effective strategy against this disease at
present. Recently, a new polymorphic gene family, the major histocompatibility complex class I chain-related (MIC) genes located
about 40kb centromeric to HLA-B gene has been proposed. This family consists of five genes (A, B, C, D and E). Among them, MICA
has five various alleles (A4, A5, A5.1, A6 and A9), which can be used as a polymorphic marker for genetic mapping and for disease
susceptibility. The MICA polymorphism was studied in our gastric cancer patients to see if there is any possible correlation with
genetic predisposition and clinicopathological factors. Genomic DNA was extracted from fresh or frozen peripheral blood leukocytes
in 107 patients with gastric adenocarcinoma who underwent gastrectomy in our hospital and 351 noncancer controls. MICA
polymorphism was analysed by using PCR-based technique. The results showed both phenotypic and allele frequencies of allele A9 in
patients with gastric cancer were significantly higher than controls (33 vs 17.6%, P¼0.005; 17 vs 9.9%, P¼0.02). Gastric
adenocarcinoma with allele A9 was associated with less schirrous change than those without (P¼0.014). MICA gene A9 allele might
confer the risk of gastric cancer and associate with less schirrous change. The mechanisms among them deserve further investigation.
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Although the global incidence of gastric cancer is decreasing,
gastric cancer is still one of the leading cancers in most Asian
countries. Its current incidence in Taiwan is 15.19 per 100000.
Since surgical resection is the principal treatment, early detection
is the only effective strategy against this disease at present. Human
leukocyte antigen (HLA) has been reported to be associated with
tumour susceptibility (Lee et al, 1996b), lymph node metastasis
(Ogoshi et al, 1996), induction of cytotoxic T-lymphocytes (Nabeta
et al, 2000) and HER-2/neu overexpression (Kono et al, 2002) in
patients with gastric adenocarcinoma. However, its application in
tumour screening or prognosis remains to be investigated.
Recently, a new polymorphic gene family, the major histocompat-
ibility complex (MHC) class I chain-related genes located about
40kb centromeric to HLA-B gene have been identified (Bahram
et al, 1994). This family consists of five genes: MHC class I chain-
related gene A (MICA), gene B (MICB), gene C (MICC), gene D
(MICD) and gene E (MICE). MICC, MICD, MICE are pseudogenes,
while MICA and MICB encode proteins that are involved in cellular
responses to stress (Bahram and Spies, 1996; Groh et al, 1998).
Among them, MICA has a triplet repeat microsatellite poly-
morphism (GCT)n in the transmembrane region, which consists of
five alleles, A4, A5, A5.1, A6 and A9 (Mizuki etal, 1997). According
to the open reading frame of the MICA cDNA, the microsatellite
encodes polyalanine and therefore the number of alanine residues
differs by the number of triplet repeats. For example, an A4 is
defined to contain four GCT repeats and A5.1 contains five triplet
repeats plus one additional nucleotide insertion (GCCT) causing a
frameshift mutation. The alleles vary among individuals, and
hence polymorphism of MICA can be used for genetic mapping
and analyses of disease susceptibility. For example, increased
frequency of MICA A6 allele was found in patients with oral
squamous cell carcinoma (Liu et al, 2002), Behcet’s disease
(Molinotti et al, 2001), and ulcerative colitis (Sugimura et al,
2001). In addition, increased frequency of A9 allele was reported in
psoriatic arthritis (Gonzalez et al, 2001) and type I diabetes (Lee
et al, 2000).
We investigated the MICA polymorphism associated with
gastric cancer patients in Taiwan in order to see if there is
possible correlation with genetic predisposition and clinicopatho-
logical factors.
PATIENTS AND METHODS
Subjects
In all, 107 consecutive gastric cancer patients who underwent
gastrectomy in Taipei-VGH were enrolled into this study and their
clinicopathological factors were recorded according to our
prospective database. A total of 351 control subjects were selected
from people who came for routine physical check up. Those with
autoimmune disorders, blood disease and previous malignancy
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drawn from the subjects to extract genomic DNA.
Polymorphysim analysis
A PCR-based polymorphism analysis was used in this study.
Genomic DNA was extracted from fresh or frozen peripheral blood
leukocytes by standard technique (Buffone and Darlington, 1985;
Lee et al, 1996a). Primers (MICA5F, 50-CCTTTTTTTCAGGGAAAG
TGC-30 and MICA5R, 50-CCTTACCATCTCCAGAAACTGC-30)
flanking the transmembrane region were designed based on the
reported sequence (Bahram et al, 1994; Ota et al, 1997). The
MICA5F primer corresponds to the intron 4 and exon 5 boundary
regions, and MICA5R is located in intron 5 (Ota et al, 1997).
MICA5R was 50 end-labelled with fluorescent dye (Applied
Biosystems, Foster City, CA, USA) (Goto et al, 1997, 1998). The
amplification reaction mixture (15ml) contained 50ng genomic
DNA, 10mM Tris-HCl (pH 9.0), 50mM KCl, 1.5mM MgCl2, 0.01%
gelatin, 0.1% Triton X-100, 0.2mM of each dNTP, 0.5mM of each
primer and 0.5U Prozyme DNA polymerase (Protech Enterprise,
Taipei, Taiwan). A GeneAmp PCR system (Perkin-Elmer Corpora-
tion, Foster City, CA, USA) was used to do the PCR reaction. The
reaction mixture was denatured at 951C for 5min followed by 10
cycles at 941C for 15s, 551C for 15s, 721C for 30s, then by an
additional 20 cycles at 891C for 15s, 551C for 15s, 721C for 30s,
and by a final extension at 721C for 10min.
Then the PCR products were denatured for 5min at 1001C,
mixed with formamide-containing stop buffer, and subjected to
electrophoresis on 4% polyacrylamide gel containing 8-M urea in
an ABI Prism 377-18 DNA sequencer (Applied Biosystem). The
number of microsatellite repeats was estimated automatically with
Genescan 672 software (Applied Biosystem) with a standard size
marker of GS-350 TAMRA (N,N,N,N-tetramethyl-6-carbonhydrox-
yl rhodamine, Applied Biosystems) (Goto et al, 1997). Alleles were
designed according to the classification of Mizuki et al (Ota et al,
1997). Their amplified sizes are 179bp (A4), 182bp (A5), 183bp
(A5.1), 185bp (A6) and 194bp (A9). At least two independent
experiments were performed on each sample to assure the analyses
were reproducible.
Analyses with clinicopathological factors
Any possible significant alteration of MICA allele will be analysed
with their clinicopathological factors, which are based on Japanese
criteria (Japanese Gastric Cancer Association, 1998) and include
age, sex, tumour location, tumour size, cellular differentiation,
gross appearance, histological patterns, stromal reaction (cancer–
stroma relationship), depth of invasion, lymph node status and
tumour stage to see if there is correlation among them. Based on
the amount of stromal tissue, stromal reaction (cancer–stroma
relationship) of gastric cancer was classified into scirrhous,
medullary and intermediate types by observation of H&E stained
pathological sections (Japanese Gastric Cancer Association, 1998).
In this study the scirrhous type was quantitatively defined as
tumour stroma occupied more than 50% of tumour area, less than
10% in medullary type and 10–50% in the intermediate type. The
three categories were determined under  40 (low power field)
magnification field.
Statistical analysis
The difference of phenotype and gene frequencies between patients
and normal controls were analysed by using w
2 test. Significant
alteration of MICA allele also was analysed with clinicaopatholo-
gical factors by using w
2 test. Statistically significant difference was
defined as Po0.05.
RESULTS
To establish the phenotypic frequencies of MICA alleles in
Taiwanese population, we have analysed 351 normal samples.
The controls’ ages ranged from 22 to 71 years (mean-
þs.d.¼42.1þ10.7). Age did not affect the MICA alleles distribu-
tion. The gender distribution of the control was 185:166, male to
female. The analyses concluded that A4 is 31%, A5 is 50%, A5.1 is
36%, A6 is 8% and A9 is 18%. This is important for this study,
since the frequencies are different in various areas (Table 1). With
this information available to us, we then analysed and compared
samples from 107 patients with gastric adenocarcinoma who
underwent gastrectomy in our hospital. Although no significant
difference of frequency of A4, A5, A5.1 and A6 alleles was found
between normal controls and gastric cancer patients, both the
phenotypic and allelic frequencies of A9 were significantly higher
than those in normal controls (33 vs 17.6%, P¼0.005; 17 vs 9.9%,
P¼0.02) (Tables 2 and 3).
We further examined whether the A9 allele might contribute to
the clinicopathological factors of these patients. Several clinico-
pathological factors such as age, sex, tumour location, size, gross
appearance, histological patterns, depth of invasion, lymph node
status and TNM staging were included in the analyses. Among
these factors, we found that gastric cancer with allele A9 was
strongly associated with less schirrous reaction (stromal reaction)
compared with ‘non-A9’ gastric tumours (P¼0.014) (Table 4),
suggesting that gastric cancer patients with allele A9 associated
with less schirrous reaction.
Table 1 Phenotypic frequencies of MICA alleles in various countries
Allele
Taiwan
a
(n¼351) (%)
Japan
b
(103) (%)
Spain
b
(342) (%)
Sweden
b
(153) (%)
A4 31 30 23 26
A5 50 52 21 56
A5.1 36 17 43 66
A6 8 46 55 9
A9 18 31 29 18
aCurrent study.
bPetersdorf et al (1999).
Table 2 Phenotype frequencies of MICA gene in gastric carcinoma patient and normal control
Normal Gastric ca
Phenotype Number (N¼351) Frequency Number (N¼107) Frequency P-value Corrected P
A4 107 30.4% 35 33% 0.663 3.315
A5 174 49.5 59 55 0.313 1.565
A5.1 127 36.1 40 37 0.821 4.105
A6 27 7.6 13 12 0.153 0.765
A9 62 17.6 35 33 0.001
a 0.005
a
aStatistic significance.
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In this study, we have shown that the MICA allele A9 was
significantly correlated with gastric adenocarcinoma and less
schirrous change in gastric cancer tissue. These findings suggest
that MICA allele A9 may be important in the etiology and immune
reaction of gastric adenocarcinoma. Although status of stromal
reaction is not routinely included in pathological report, it was
reported to be a prognostic indicator of gastric cancer (Wu et al,
1997). Stromal reaction of tumour was shown to relate with cancer
desmoplastic reaction (Ohtani et al, 1992), angiogenesis (Engels
et al, 1997), tumour invasion and metastasis, tumour cell
proliferation (Wernet, 1997), and immune reactions (Saiki et al,
1996). Tumour stroma is composed of new blood vessels,
inflammatory cells and connective tissue (Dvorak, 1986). Tumour
stromal reaction include many complicated interrelated processes,
including production of cytokine (interleukine) to induce immune
T cells to elicit tumour regression (Nabeta et al, 2000), expressing
adhesion molecules and production of matrix-degrading enzyme
by stromal cells to facilitate tumour invasion and metastasis
(Wernet, 1997). Currently, the cellular and molecular events of
stromal reaction were proposed to be similar to those of wound
healing (Dvorak, 1986) and inflammatory diseases, such as
ulcerative disease and Crohn’s disease (Ohtani, 1998). In these
inflammatory lesions, the aberration of the immune system is
speculated to be the cause of the diseases. Stromal reaction of
Table 3 Allelic frequencies of MICA gene in gastric carcinoma patient and normal control
Normal Gastric ca
Allele Number (N¼702) Frequency Number (N¼214) Frequency P-value Corrected P
A4 161 22.9% 41 19% 0.244 1.22
A5 262 37.3 73 34 0.393 1.965
A5.1 177 25.2 49 23 0.491 2.455
A6 32 4.5 14 7 0.245 1.225
A9 70 9.9 37 17 0.004
a 0.02
a
aStatistic significance.
Table 4 Clinicopathological features of gastric cancer with A9
phenotype MICA
MICA phenotype
Parameter A9 (n¼35) Non-A9 (n¼72) P-value
Age
o65 15 26 0.617
465 20 46
Sex
Male 26 55 0.978
Female 9 17
Tumour location
Upper 1/3 7 9 0.512
Middle 1/3 10 28
Lower 1/3 18 34
Whole 0 1
Tumour size
o4cm 19 30 0.287
4–8cm 12 35
48cm 4 7
Cell differentiation
Well 1 1 0.424
Moderate 19 30
Poor 15 41
Borrmann type
0 19 30 0.256
I+II 5 11
III+IV 11 31
Infiltration type
Alpha 12 24 0.466
Beta 12 18
Gamma 11 31
Stromal reaction
Medullary 9 23 0.014
a
Intermediate 25 33
Schirrous 1 16
Ming classification
Infiltrative 15 26 0.560
Expanding 20 46
Lauren’s classification
Intestinal type 22 36 0.191
Diffuse type 13 36
Depth of tumour invasion
T1 14 28 0.744
T2 6 10
T3+T4 15 34
Lymph node metastasis
Negative 23 36 0.123
Positive 12 36
Liver metastasis
Negative 33 71 0.221
Positive 2 1
Peritoneal dissemination
Negative 34 70 1.000
Positive 1 2
TNM stage
I 18 34 0.292
II 7 6
III 6 21
IV 4 11
aStatistic significance.
Table 4 (Continued)
MICA phenotype
Parameter A9 (n¼35) Non-A9 (n¼72) P-value
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ytumour can also be regarded as an immune response to a
neogrowth. Therefore, the host immune reactions can be regarded
as a factor in modulating the aggressiveness of a tumour. For
desmoplastic reaction, it is still uncertain whether it is defensive
for the host or it is facilitating the tumour growth, although a
poorer survival was reported in patients with gastric cancer and
breast cancer (Cardone et al, 1997; Caporale et al, 2001). As shown
in the current study, less scirrhous (less desmoplastic reaction)
type tumour appeared in A9 allele group (P¼0.014) and was
probably resulted from some host immune mechanism.
MICA encodes a molecule similar to MHC class I antigens and
may share the same capacity of binding to short peptides or small
ligands. MICA is expressed in fibroblasts, epithelial cells (Bahram
et al, 1994), keratinocytes, endothelial cells and monocytes
(Zwirner et al, 1998), and may play a role in the immune response
(Bahram et al, 1994). Its expression is regulated by a promoter heat
shock element similar to those of heat shock protein (HSP) genes
(Groh et al, 1996). High levels of MICA expression in epithelial cell
lines together with upregulation of MICA after heat shock may
represent a new molecular mechanism of exposing stressed
epithelial cells to the immune system (Bahram et al, 1996). It is
shown that HSPs are involved in the formation of malignancy
(Bonay et al, 1994; Kawanishi et al, 1999), including gastric
adenocarcinoma (Liu et al, 1999; Maehara et al, 2000). In addition,
they are expressed by transformed/cancer cells, which are
important targets for T lymphocytes. High levels of MICA
expression in epithelial cells after heat shock (stress) may not be
coincident. It may provide a mechanism of exposing transformed
cells to the mucosal immune system allowing gd T cells (Bahram
et al, 1996; Groh et al, 1998), a subset of T cells expressing the gd T
cell receptors (TCRs) g/d heterodimer (Haas et al, 1993), to
recognise and destroy transformed/damaged cells. Although gd T
cells constitute only about 5% of circulating T cells, they are
distributed throughout the human intestinal epitheliaum and may
function as sentinels that respond to self-antigens. Interestingly,
MICA is almost exclusively expressed intestinal epitheliaum.
Recently, it was shown that NK cells and antigen-specific effector
T cells could be triggered by MIC engagement of NKG2D (Bauer
et al, 1999), a receptor expressed on most NK cells, gd T cells and
CD8 gd T cells involved in the innate and adaptive immune
responses (Bauer et al, 1999). However, circulatory MICA secreted
by neoplasms can downregulate the expression of NKG2D and
impair the responsiveness of effector T cells (Groh et al, 2001).
Whether MICA A9 antigen product can result in altered immunity
and susceptibility to gastric cancer via reactions with HSPs or gd T
cell or NKG2D need further investigation (Groh et al, 1998, 2001,
2002; Bauer et al, 1999).
In summary, all of the above findings suggesting MICA may
relate with host immunity. Since its alleles vary among individuals
and may confer variable disease susceptibility, analyses of MICA
alleles maybe useful in cancer investigation. Our results demon-
strated that Taiwanese carrying an A9 allele have higher risk to
gastric cancer. Furthermore, gastric cancers with A9 allele are
associated with less schirrous change. Further investigation can
study the mechanism of activity of MICA A9 allele. Identification
of the mechanism of association of MICA A9 allele with gastric
cancer could help the individuals most likely benefit from cancer
screening and prevention program and may suggest novel
treatment modality.
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